SFM
TENX icon

Sphera Funds Management’s Tenax Therapeutics TENX Stock Holding History

Sphera Funds Management’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.17M Sell
136,015
-54,096
-28% -$732K 0.35% 78
2025
Q4 		$2.32M Buy
+190,111
New +$1.65M 0.45% 71
2024
Q4 		– Sell
-29,166
Closed -$101K – 130
2024
Q3 		$101K Buy
+29,166
New +$106K 0.02% 114

Other funds holding TENX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Sphera Funds Management's TENX Position: Q1 2026 in Review

Sphera Funds Management reduced its Tenax Therapeutics (TENX) stake by 28% in Q1 2026, selling an estimated $732K and leaving 136,015 shares worth $2.17M. The position accounts for 0.35% of the portfolio, ranked #78.

Sphera Funds Management first reported a position in TENX in Q3 2024 and has held it in 3 quarters since. The position peaked at $2.32M in Q4 2025. 80 funds tracked by Wall St. Rank hold TENX as of Q1 2026.

  • Sphera Funds Management held 136,015 shares of Tenax Therapeutics worth $2.17M as of Q1 2026.
  • Sphera Funds Management sold 54,096 Tenax Therapeutics shares in Q1 2026, an estimated $732K.
  • Tenax Therapeutics made up 0.35% of Sphera Funds Management's portfolio in Q1 2026, its #78 holding.
  • Sphera Funds Management first reported a position in Tenax Therapeutics in Q3 2024 and has held it in 3 quarters since.
  • Sphera Funds Management's Tenax Therapeutics position peaked at $2.32M in Q4 2025.
  • 80 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q1 2026.

Based on Sphera Funds Management's 13F filing for Q1 2026, filed 15 May 2026.